Eligibility criteria
Condition
Bipolar Disorder
Sex
Females and Males
Age
10-17 years
Inclusion criteria
Show details
- The subjects must have received study medication in Study A1281196.
- In the investigator's opinion, the subject must be likely to continue to benefit from
antipsychotic therapy and must have been free from any clinically significant safety
concerns during the preceding double blind study.
Exclusion criteria
Show details
- Subjects who require treatment with drugs that are known to consistently prolong the
QT interval.
- Subjects who are judged by the investigator as being at imminent risk of suicide.